July 6, 20234:48 PM ET Heard on Morning Edition Jon Hamilton The Food and Drug Administration has fully approved Leqembi, the first drug shown to slow down Alzheimer’s disease. Andrew Harnik/AP The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer’s disease. The action means that Leqembi, whose…
Read MoreUpdated March 29, 20224:21 PM ET Heard on Morning Edition Rob Stein And Jane Greenhalgh The recommendation comes as BA.2, an even more contagious version of the omicron variant, continues to spread in the U.S., and concern mounts that it could fuel another surge. BA.2 is now the dominant strain in the U.S., making up…
Read MoreThe Food and Drug Administration on Monday approved the first new treatment for Alzheimer’s disease in nearly two decades, a landmark decision that has been eagerly awaited by millions of Americans diagnosed with the condition but that will be hotly contested by some in the scientific community who doubt the drug’s effectiveness. Read More…
Read MoreCVS to begin vaccinating Texas senior living facilities Monday after Christmas By Jessica Bartlett – Reporter, Boston Business Journal Dec 21, 2020, 10:28am EST CVS will roll out coronavirus vaccines to more than 2,000 senior living facilities in Texas starting Dec. 28 as part of a nationwide distribution at more than 40,000 senior living facilities throughout the country. …
Read More